Search

everythinglearnresearchcommunity

for

Search:↓

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

SOX4 is crucial for the development of melanoma.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

UV photography can help identify people at higher risk for skin cancer, and male pattern baldness at age 45 is linked to a higher risk of certain skin cancers.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Many men with androgenic alopecia also have dyslipidemia.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeting lipid metabolism can help treat advanced, resistant cancers.

The model and estimator can predict drug exposure in kidney transplant patients well.

A group has developed therapies that show promise for treating cancer and various other conditions.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

FGF12 is important for hair growth and could be targeted for hair loss treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.